185 related articles for article (PubMed ID: 35978337)
41. Modeling of protein refolding from inclusion bodies.
Zhang T; Xu X; Shen L; Feng Y; Yang Z; Shen Y; Wang J; Jin W; Wang X
Acta Biochim Biophys Sin (Shanghai); 2009 Dec; 41(12):1044-52. PubMed ID: 20011979
[TBL] [Abstract][Full Text] [Related]
42. Accurate quantitation for in vitro refolding of single domain antibody fragments expressed as inclusion bodies by referring the concomitant expression of a soluble form in the periplasms of Escherichia coli.
Noguchi T; Nishida Y; Takizawa K; Cui Y; Tsutsumi K; Hamada T; Nishi Y
J Immunol Methods; 2017 Mar; 442():1-11. PubMed ID: 27939301
[TBL] [Abstract][Full Text] [Related]
43. In vitro refolding of cyclomaltodextrin glucanotransferase from cytoplasmic inclusion bodies formed upon expression in Escherichia coli.
Hellman J; Lassila P; Mäntsälä P
Protein Expr Purif; 1995 Feb; 6(1):56-62. PubMed ID: 7756839
[TBL] [Abstract][Full Text] [Related]
44. Non-denaturing solubilization of inclusion bodies.
Tsumoto K; Abe R; Ejima D; Arakawa T
Curr Pharm Biotechnol; 2010 Apr; 11(3):309-12. PubMed ID: 20210737
[TBL] [Abstract][Full Text] [Related]
45. Molecular Attributes Associated With Refolding of Inclusion Body Proteins Using the Freeze-Thaw Method.
Singhvi P; Verma J; Panwar N; Wani TQ; Singh A; Qudratullah M; Chakraborty A; Saneja A; Sarkar DP; Panda AK
Front Microbiol; 2021; 12():618559. PubMed ID: 33959102
[TBL] [Abstract][Full Text] [Related]
46. Isolation, solubilization, refolding, and chromatographic purification of human growth hormone from inclusion bodies of Escherichia coli cells: a case study.
Singh SM; Eshwari AN; Garg LC; Panda AK
Methods Mol Biol; 2005; 308():163-76. PubMed ID: 16082034
[No Abstract] [Full Text] [Related]
47. Purification of viral neuraminidase from inclusion bodies produced by recombinant Escherichia coli.
Lipničanová S; Chmelová D; Godány A; Ondrejovič M; Miertuš S
J Biotechnol; 2020 Jun; 316():27-34. PubMed ID: 32302655
[TBL] [Abstract][Full Text] [Related]
48. Integrated refolding techniques for Schistosoma japonicum MTH1 overexpressed as inclusion bodies in Escherichia coli.
Feng Y; Liu L; Wang J; Liu J; Hu W; Wang X; Yang Z
Protein Expr Purif; 2012 Aug; 84(2):181-7. PubMed ID: 22641057
[TBL] [Abstract][Full Text] [Related]
49. Improved Refolding of a Human IgG1 Fc (CH2-CH3) Scaffold from Its Inclusion Body in E. coli by Alkaline Solubilization.
Ishikawa S; Ishikawa H; Sato A
Biol Pharm Bull; 2022; 45(3):284-291. PubMed ID: 35228394
[TBL] [Abstract][Full Text] [Related]
50. Thiol-Disulfide Exchange in Human Growth Hormone.
Chandrasekhar S; Moorthy BS; Xie R; Topp EM
Pharm Res; 2016 Jun; 33(6):1370-82. PubMed ID: 26887678
[TBL] [Abstract][Full Text] [Related]
51. Refolding and structural characteristic of TRAIL/Apo2L inclusion bodies from different specific growth rates of recombinant Escherichia coli.
Kang H; Sun AY; Shen YL; Wei DZ
Biotechnol Prog; 2007; 23(1):286-92. PubMed ID: 17269700
[TBL] [Abstract][Full Text] [Related]
52. A single step method for the solubilization and refolding of recombinant protein from E. coli inclusion bodies.
Crivelli E; Cardamone M; Puri NK
Aust J Biotechnol; 1991 Apr; 5(2):78-80, 86. PubMed ID: 1367324
[TBL] [Abstract][Full Text] [Related]
53. Nucleic acids in inclusion bodies obtained from E. coli cells expressing human interferon-gamma.
Krachmarova E; Ivanov I; Nacheva G
Microb Cell Fact; 2020 Jul; 19(1):139. PubMed ID: 32652996
[TBL] [Abstract][Full Text] [Related]
54. Bioprocessing of recombinant proteins from
Kachhawaha K; Singh S; Joshi K; Nain P; Singh SK
Prep Biochem Biotechnol; 2023; 53(7):728-752. PubMed ID: 36534636
[TBL] [Abstract][Full Text] [Related]
55. Expression, high-pressure refolding and purification of human leukocyte cell-derived chemotaxin 2 (LECT2).
Zheng H; Miyakawa T; Sawano Y; Yamagoe S; Tanokura M
Protein Expr Purif; 2013 Apr; 88(2):221-9. PubMed ID: 23337084
[TBL] [Abstract][Full Text] [Related]
56. Characterization of the 4,6-α-glucanotransferase GTFB enzyme of Lactobacillus reuteri 121 isolated from inclusion bodies.
Bai Y; van der Kaaij RM; Woortman AJ; Jin Z; Dijkhuizen L
BMC Biotechnol; 2015 Jun; 15():49. PubMed ID: 26050651
[TBL] [Abstract][Full Text] [Related]
57. Comparing the refolding and reoxidation of recombinant porcine growth hormone from a urea denatured state and from Escherichia coli inclusion bodies.
Cardamone M; Puri NK; Brandon MR
Biochemistry; 1995 May; 34(17):5773-94. PubMed ID: 7727438
[TBL] [Abstract][Full Text] [Related]
58. Prokaryotic soluble overexpression and purification of bioactive human growth hormone by fusion to thioredoxin, maltose binding protein, and protein disulfide isomerase.
Nguyen MT; Koo BK; Thi Vu TT; Song JA; Chong SH; Jeong B; Ryu HB; Moh SH; Choe H
PLoS One; 2014; 9(3):e89038. PubMed ID: 24614134
[TBL] [Abstract][Full Text] [Related]
59. Intensification of Inclusion Body Processing via Temperature-Based Refolding.
Wong RS; Alias NNM; Ong EBB; Liew MWO
Methods Mol Biol; 2023; 2617():189-200. PubMed ID: 36656525
[TBL] [Abstract][Full Text] [Related]
60. Efficient production of a correctly folded mouse α-defensin, cryptdin-4, by refolding during inclusion body solubilization.
Tomisawa S; Sato Y; Kamiya M; Kumaki Y; Kikukawa T; Kawano K; Demura M; Nakamura K; Ayabe T; Aizawa T
Protein Expr Purif; 2015 Aug; 112():21-8. PubMed ID: 25913370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
